Clinical Trial Update: Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating testosterone revival to reduce negative symptoms, achieve objective responses, and modulate enzalutamide resistance in cast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration Resistant Metastatic Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Testosterone revival therapy

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Castration Resistant Metastatic Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-05-01